The Lancet Digital Health, Год журнала: 2024, Номер 7(1), С. e4 - e5
Опубликована: Дек. 24, 2024
Язык: Английский
The Lancet Digital Health, Год журнала: 2024, Номер 7(1), С. e4 - e5
Опубликована: Дек. 24, 2024
Язык: Английский
npj Digital Medicine, Год журнала: 2024, Номер 7(1)
Опубликована: Июнь 18, 2024
Wearable sensor technologies are becoming increasingly relevant in health research, particularly the context of chronic disease management. They generate real-time data that can be translated into digital biomarkers, which provide insights our and well-being. Scientific methods to collect, interpret, analyze, translate from wearables biomarkers vary, systematic approaches guide these processes currently lacking. This paper is based on an observational, longitudinal cohort study, BarKA-MS, collected wearable physical rehabilitation people living with multiple sclerosis (MS). Based experience we discuss ten lessons learned relation biomarker development across key study phases. We then summarize a guiding framework (DACIA) aims informs use for management future research teaching.
Язык: Английский
Процитировано
7Опубликована: Авг. 12, 2024
Язык: Английский
Процитировано
0PLOS Digital Health, Год журнала: 2024, Номер 3(11), С. e0000645 - e0000645
Опубликована: Ноя. 6, 2024
Remote longitudinal studies are on the rise and promise to increase reach reduce participation barriers in chronic disease research. However, maintaining long-term retention these remains challenging. Early identification of participants with different patterns offers opportunity for tailored survey adaptations. Using data from online arm Swiss Multiple Sclerosis Registry (SMSR), we assessed sociodemographic, health-related, daily-life related baseline variables against measures follow-up surveys through multivariable logistic regressions unsupervised clustering analyses. We further explored completion requirements inform future designs. Our analysis included 1,757 who completed a median 4 (IQR 2–8) after maximum 13 possible surveys. Survey start year, age, citizenship, MS type, symptom burden independent driving were significant predictors at baseline. Three clusters emerged, no differences outcomes revealed across clusters. Exploratory assessments suggest trends increased complexity lower rates completion. findings offer insights into characteristics associated remote studies, yet they also highlight influence various unexplored factors outcomes. Future should incorporate additional objective that reflect participants’ individual contexts understand their ability remain engaged adaptations accordingly.
Язык: Английский
Процитировано
0JMIR Formative Research, Год журнала: 2024, Номер unknown
Опубликована: Авг. 12, 2024
Medication nonadherence is a serious problem in cancer, potentially impacts patients' health outcomes and care costs. Although technology-based medication adherence (MA) interventions have emerged, evidence supporting their quality effectiveness remains limited. This study tested the acceptability, feasibility, potential effects of Safety Adherence to Medications Self-care Advice Oncology (SAMSON), digital solution designed support MA self-management cancer. A 12-week, 2-arm, unblinded, pragmatic pilot randomized controlled trial was conducted. Adults with hematological malignancies who started oral cancer medicines within last 12 months were recruited from metropolitan specialized hospital 1:1 SAMSON or control (usual care). The included smartphone app tailored alerts real-time self-care advice, web-based dashboard for professionals (HCPs) monitor symptoms, motivational interviewing (MI) teleconsultations delivered by oncology nurses pharmacists at baseline weeks 1, 4, 8, 12. Primary acceptance SAMSON, measured Unified Theory Acceptance Use Technology weeks, predefined rates recruitment, randomization, retention, intervention adherence, outcome assessment completion. Secondary comparison clinical self-assessments through online questionnaires, including toxicity self-management, anxiety depression life, between 2 arms. Data retrieved (Swinburne University Technology) analysed task total 33 patients (79% those approached) consented participate trial. Of those, 31/33 (94%) completed surveys (15/31) arms (16/31). 31 patients, 28 (90%) 12-week (12 16 control). Overall, rated as highly acceptable (13/15, 87% usage; 14/15, 93% MI teleconsultation delivery). They reported that easy use (10/12, 83%) helpful improving (6/12, 50%). All HCPs MA. Patients an average 99 tasks over period (71% scheduled tasks). Most all 5 consultations. feasibility measures higher than upper thresholds, except rate responses reminders. results demonstrated acceptable, usable, useful feasible real-life settings. Our next steps involve refining based on participants' feedback, conducting large-scale evaluate its economic effectiveness, exploring commercialization. Australian New Zealand Clinical Trials Registry ACTRN12623000472673; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385728. RR2-10.1136/bmjopen-2023-079122.
Язык: Английский
Процитировано
0The Lancet Digital Health, Год журнала: 2024, Номер 7(1), С. e4 - e5
Опубликована: Дек. 24, 2024
Язык: Английский
Процитировано
0